Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD): Beat/Raise Should Assuage Fears - Baird

July 27, 2017 8:22 AM
Baird analyst, Brian Skorney, reiterated his Outperform rating on shares of Gilead Sciences (NASDAQ: GILD) even though HCV sales didn't ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles